Spiess Bernhard E. 4
4 · CASTLE BIOSCIENCES INC · Filed Sep 7, 2021
Insider Transaction Report
Form 4
Spiess Bernhard E.
Chief Operating Officer
Transactions
- Exercise/Conversion
Common Stock
2021-09-02$2.39/sh+6,412$15,325→ 28,963 total - Sale
Common Stock
2021-09-02$76.14/sh−5,889$448,388→ 15,036 total - Sale
Common Stock
2021-09-02$75.24/sh−8,038$604,779→ 20,925 total - Exercise/Conversion
Common Stock
2021-09-02$1.92/sh+8,989$17,259→ 22,551 total - Sale
Common Stock
2021-09-02$77.29/sh−1,474$113,925→ 13,562 total - Exercise/Conversion
Stock option (right to buy)
2021-09-02−8,989→ 5,889 totalExercise: $1.92Exp: 2026-05-23→ Common Stock (8,989 underlying) - Exercise/Conversion
Stock option (right to buy)
2021-09-02−6,412→ 2,304 totalExercise: $2.39Exp: 2028-05-09→ Common Stock (6,412 underlying)
Footnotes (6)
- [F1]These transactions were made pursuant to a Rule 10b5-1 plan adopted by the Reporting Person on August 19, 2021.
- [F2]This transaction was executed in multiple trades at prices ranging from $74.59 to $75.58, inclusive. The price reported above reflects the weighted-average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- [F3]This transaction was executed in multiple trades at prices ranging from $75.60 to $76.45, inclusive. The price reported above reflects the weighted-average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- [F4]This transaction was executed in multiple trades at prices ranging from $76.70 to $77.63, inclusive. The price reported above reflects the weighted-average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- [F5]25% of the 169,592 shares originally subject to the option vested on May 2, 2017, and the remaining shares vested in 36 equal monthly installments thereafter.
- [F6]25% of the 12,305 shares originally subject to the option vested on May 10, 2019, and the remaining shares vest in 36 equal monthly installments thereafter.